The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The PRODIGE 59-DURIGAST trial: A randomized phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-esophageal junction adenocarcinoma.
 
David Tougeron
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Sanofi
 
Laetitia Dahan
Honoraria - AMGEN; BMS; MYLAN; OSEUS; SERVIER
 
Farid El Hajbi
No Relationships to Disclose
 
Karine Le Malicot
No Relationships to Disclose
 
Ludovic Evesque
No Relationships to Disclose
 
Thomas Aparicio
Honoraria - AMGEN; AstraZeneca; Pierre Fabre; Servier
Consulting or Advisory Role - BIOVEN; MSD Oncology; Pierre Fabre; Servier; Sirtex Medical
Travel, Accommodations, Expenses - MSD Oncology
 
Olivier Bouché
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Nathalie Bonichon-Lamichhane
No Relationships to Disclose
 
Benoist Chibaudel
Consulting or Advisory Role - Bayer; Pfizer; Roche; Sanofi; Servier
Travel, Accommodations, Expenses - Amgen; Merck; MSD; Roche; Sanofi
 
Antoine Angelergues
Honoraria - GlaxoSmithKline
 
Anais Bordere
No Relationships to Disclose
 
Jean-Marc Phelip
No Relationships to Disclose
 
May Mabro
No Relationships to Disclose
 
Pascal Artru
No Relationships to Disclose
 
Christophe Louvet
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Roche
Travel, Accommodations, Expenses - Merck; Roche